IRB REVIEWER FORM.INITIAL REVIEW.SECTION 1: STUDY TITLE & IRB FILE.SECTION 2: PRINCIPAL INVESTIGATOR PRIMARY CONTACT INFORMATION.Principal Investigator.Please use this checklist for reference when reviewing this protocol. Make notes in the space provided
IRB Protocol Title.Principal Investigator on Protocol.1. Name of device.2. Name of IDE or HDE holder.3. Has the device been approved by the FDA? Yes No.If yes, complete Item a.a. Does the proposed research use the device for the purposes for which it has been approved? Yes No
Name of Project.PI Telephone Number.PI Email Address.VI. Box Below For IRB Use Only.Page 1 of 5 Investigational Device Form
Collaborative Institutional Training Initiative (CITI).The VA Office of Research and Development (ORD) and Collaborative Institutional Training Initiative (CITI) have developed a training curriculum that satisfies ORD training requirements
Office of Human Research Ethics.Institutional Review Board.Application for IRB Approval of Human Subjects Research.Part A.1. Contact Information, Agreements, and Signatures.Title of Study: PHR Needs Assessment Date: 2/7/06.Name and degrees of Principal Investigator: Barbara Wildemuth
Center for Clinical Ethics and Humanities in Health Care.Bioethics Bulletin.Editor: Tim Madigan.August 1997 Volume Four, Number Eight.Co-Directors: Gerald Logue, MD and Stephen Wear, PhD Associate Director: Jack Freer, MD Research Associate: Adrianne
Institutional Review Board Introduction and FAQ.What is the Institutional Review Board (IRB)?.The Adler Graduate School Institutional Review Board (IRB) oversees all proposals for Master s Projects or other academic projects involving human participants
GENERAL INFORMATION FOR.RVEEH HUMAN RESEARCH & ETHICS COMMITTEE.Role and Membership of the Committee.The Royal Victorian Eye & Ear Hospital s Human Research and Ethics Committee (HREC) is a multi-disciplinary committee established in accordance with National
NIH-FDA Phase 2 and 3 IND/IDE Clinical Trial Protocol Template.Remove this Preface before finalizing and distributing the clinical trial protocol.This clinical trial protocol template is a suggested format for Phase 2 and 3 clinical trials funded by the
NATIONAL INSTITUTES OF HEALTH (NIH) APPLICATION FOR LICENSE FOR BIOLOGICAL MATERIALS (INTERNAL USE OR COMMERCIAL).Thank you for your interest in technology transfer activities at the NIH. A completed application is required before any action can be taken
If this evaluation refers to a local investigator-initiated study, PAGE 3 of this form should be also completed for submission to SRC.Scientific Interest.Potential Clinical Significance.Value Added By Consortium Participation.Anticipated Accrual*.Competing Trials in Consortium
Ethical Decision-Making 5.Running Head: Using Ethical Decision-Making Model In Clinical Practice.Using Ethical Decision-Making Model In Clinical Practice.Carmilo Vannucci.NURS3013 29122S Issues and Trends in Nursing, Jill Hasley, MNSc., RN.Southern Arkansas University School of Nursing
Formed in 2005, the Work Group provides a forum for health education and communications staff from NIH Institutes and Centers to share strategies and effective communication approaches to develop and disseminate health information for American Indian and Alaska Native communities
Participant Identification Code Key.Purpose: The Participant Identification Code Key template will link the assigned study identification (ID) number to the actual patient identity. This template can be used to link enrolled participant identity or protected
Opinion of Principal Investigator.and Determination by UConn Health Oversight Bodies.Regarding Need for Review by the NIH Research Advisory Committee.In March of 2016 changes to the human gene transfer protocol review process were made by NIH, in consultation
Jemds.comOriginal Research Article.A COMPARATIVE STUDY OF INTRAVENOUS ONDANSETRON, GRANISETRON AND RAMOSETRON FOR PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING IN PATIENTS UNDERGOING CAESAREAN SECTION.Bansal Suman R1, Ramtani Umesh2, Bansal Rohan3